Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

192 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Active Breathing Coordinator in adjuvant three-dimensional conformal radiotherapy of early stage breast cancer: a feasibility study.
Massaccesi M, Caravatta L, Cilla S, Digesù C, Deodato F, Macchia G, Picardi V, Piscopo A, Padula GD, Ferrandina G, Scambia G, Valentini V, Cellini N, Piermattei A, Morganti AG. Massaccesi M, et al. Among authors: piermattei a. Tumori. 2010 May-Jun;96(3):417-23. doi: 10.1177/030089161009600307. Tumori. 2010. PMID: 20845802 Clinical Trial.
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients.
Morganti AG, Cilla S, Valentini V, Digesu' C, Macchia G, Deodato F, Ferrandina G, Cece MG, Cirocco M, Garganese G, Di Lullo L, Traficante D, Scarabeo F, Panunzi S, De Gaetano A, Sallustio G, Cellini N, Sofo L, Piermattei A, Scambia G. Morganti AG, et al. Among authors: piermattei a. Radiother Oncol. 2009 Jan;90(1):86-92. doi: 10.1016/j.radonc.2008.10.017. Epub 2008 Nov 17. Radiother Oncol. 2009. PMID: 19010560 Clinical Trial.
Feasibility study of moderately accelerated intensity-modulated radiotherapy plus concurrent weekly cisplatin after induction chemotherapy in locally advanced head-and neck cancer.
Morganti AG, Mignogna S, Deodato F, Massaccesi M, Cilla S, Calista F, Serafini G, Digesú C, Macchia G, Picardi V, Caravatta L, Di Lullo L, Giglio G, Sallustio G, Piermattei A, Cellini N, Valentini V. Morganti AG, et al. Among authors: piermattei a. Int J Radiat Oncol Biol Phys. 2011 Mar 15;79(4):1073-80. doi: 10.1016/j.ijrobp.2009.12.020. Epub 2010 May 14. Int J Radiat Oncol Biol Phys. 2011. PMID: 20472342
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: a dose-escalation trial.
Ippolito E, Cellini N, Digesù C, Cilla S, Mantini G, Balducci M, Di Lallo A, Deodato F, Macchia G, Massaccesi M, Mattiucci GC, Tagliaferri L, Piermattei A, Cuscunà D, Morganti AG. Ippolito E, et al. Among authors: piermattei a. Urol Oncol. 2013 Jan;31(1):87-92. doi: 10.1016/j.urolonc.2010.10.005. Epub 2011 Apr 1. Urol Oncol. 2013. PMID: 21458315
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When?
Morganti AG, Cilla S, de Gaetano A, Panunzi S, Digesù C, Macchia G, Massaccesi M, Deodato F, Ferrandina G, Cellini N, Scambia G, Piermattei A, Valentini V. Morganti AG, et al. Among authors: piermattei a. J Appl Clin Med Phys. 2011 Jan 31;12(2):3451. doi: 10.1120/jacmp.v12i2.3451. J Appl Clin Med Phys. 2011. PMID: 21587195 Free PMC article.
Daily on-line set-up correction in 3D-conformal radiotherapy: is it feasible?
Deodato F, Cilla S, Massaccesi M, Macchia G, Ippolito E, Caravatta L, Picardi V, Romanella M, Di Falco C, Bartollino A, Valentini V, Cellini N, De Spirito M, Piermattei A, Morganti AG. Deodato F, et al. Among authors: piermattei a. Tumori. 2012 Jul-Aug;98(4):441-4. doi: 10.1177/030089161209800407. Tumori. 2012. PMID: 23052159
192 results